Genetic alterations of PTEN in human melanoma (Q37955107)

25 August 2017

Genetic alterations of PTEN in human melanoma (English)

1 reference

25 August 2017

Almass-Houd Aguissa-Touré

series ordinal

1

1 reference

PubMed ID

22076652

25 August 2017

Gang Li

series ordinal

2

1 reference

25 August 2017

11 November 2011

1 reference

Cellular and Molecular Life Sciences

25 August 2017

1 reference

25 August 2017

69

1 reference

25 August 2017

1475-1491

1 reference

25 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-011-0878-0

25 August 2017

0 references

cites work

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN mutation spectrum in breast cancers and breast hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Identification of PTEN mutations in metastatic melanoma specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN hamartoma tumor syndrome: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN: one gene, many syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Protean PTEN: form and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

The multiple roles of PTEN in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Pten, a protean tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Both lipid- and protein-phosphatase activities of PTEN contribute to the p53-PTEN anti-invasion pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

From form to function: signaling by protein tyrosine phosphatases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Crystal structure of the dual specificity protein phosphatase VHR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN promoter methylation in sporadic thyroid carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Promoter methylation and silencing of PTEN in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN signaling pathways in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

21 January 2018

New insights into PTEN.

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Post-translational regulation of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Ubiquitination regulates PTEN nuclear import and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Faithfull modeling of PTEN loss driven diseases in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Pten is essential for embryonic development and tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN and the PI3-kinase pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Subtle variations in Pten dose determine cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Reduction of Pten dose leads to neoplastic development in multiple organs of Pten (shRNA) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

The role of PTEN signaling perturbations in cancer and in targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Mutations of the human PTEN gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Epigenetic PTEN silencing in malignant melanomas without PTEN mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN expression in melanoma: relationship with patient survival, Bcl-2 expression, and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Molecular genetics of familial cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Cooperative effects of INK4a and ras in melanoma susceptibility in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 3-kinase and Akt activities exert opposing effects on the ERK pathway: importance for the rescue of neuroectodermic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Regulation of Raf-Akt Cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Distinct sets of genetic alterations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Toward a molecular classification of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

BRAF mutation predicts sensitivity to MEK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN signaling pathways in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Integrating BRAF/MEK inhibitors into combination therapy for melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN: sometimes taking it off can be better than putting it on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

The lipid phosphatase activity of PTEN is critical for its tumor supressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Essential role for nuclear PTEN in maintaining chromosomal integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

APC/C-Cdh1: from cell cycle to cellular differentiation and genomic integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

BRAF alterations are associated with complex mutational profiles in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

T Cell-Specific Loss of Pten Leads to Defects in Central and Peripheral Tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Loss of heterozygosity in sporadic primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0878-0

Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.

21 January 2018

1 reference

12 December 2020

MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines

1 reference

12 December 2020

Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia

1 reference

12 December 2020

Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma

1 reference

12 December 2020

Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.

1 reference

12 December 2020

PTEN/MMAC1 mutations in endometrial cancers.

1 reference

12 December 2020

Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies

1 reference

12 December 2020

Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.

1 reference

12 December 2020

Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma

1 reference

12 December 2020

Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.

1 reference

12 December 2020

Loss of heterozygosity for 10q22-10qter in malignant melanoma progression

1 reference

12 December 2020

Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

1 reference

12 December 2020

Chromosome 10 allelic loss in malignant melanoma

1 reference

12 December 2020

1 reference

12 December 2020

PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma

1 reference

12 December 2020

Allelic loss on chromosome 10 in prostate adenocarcinoma

1 reference

12 December 2020

PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo

1 reference

12 December 2020

Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma

1 reference

12 December 2020

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

1 reference

12 December 2020

The PTEN tumour suppressor gene and malignant melanoma.

1 reference

12 December 2020

Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene

1 reference

12 December 2020

Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland

1 reference

12 December 2020

Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas

1 reference

12 December 2020

The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells

1 reference

12 December 2020

Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies

1 reference

12 December 2020

Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF

1 reference

12 December 2020

Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors

1 reference

12 December 2020

Anticorresponding mutations of the KRAS and PTEN genes in human endometrial cancer

1 reference

12 December 2020

Prostate cancer in Cowden syndrome: somatic loss and germline mutation of the PTEN gene

1 reference

12 December 2020

Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation

1 reference

12 December 2020

Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues

1 reference

12 December 2020

TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta

1 reference

12 December 2020

Epigenetic silencing of the PTEN gene in melanoma

1 reference

12 December 2020

PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines

1 reference

12 December 2020

Somatic mutations of PTEN in glioblastoma multiforme.

1 reference

12 December 2020

Methylation of PTEN as a prognostic factor in malignant melanoma of the skin

1 reference

12 December 2020

Promoter methylation of the PTEN gene is a common molecular change in breast cancer

1 reference

12 December 2020

PTEN/MMAC1 in malignant melanoma and its importance for tumor progression

1 reference

12 December 2020

PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma

1 reference

12 December 2020

Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias

1 reference

12 December 2020

PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas

1 reference

12 December 2020

10.1007/S00018-011-0878-0

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22076652